ZetrOZ, Inc.
17
3
3
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.8%
2 terminated/withdrawn out of 17 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
42%
5 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Role: lead
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
Role: lead
Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
Role: lead
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Role: lead
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Role: lead
Sustained Acoustic Medicine for Osteoarthritis Pain
Role: lead
Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis
Role: lead
Long-Duration Ultrasound for Knee Osteoarthritis
Role: lead
Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
Role: lead
Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
Role: lead
Low Intensity Ultrasound Therapy for Upper Back Pain Relief
Role: lead
Real-World Experience of Athletes Treated With SAM
Role: lead
Wearable LITUS Device for Osteoarthritis of the Knee: a Randomized Double-Blind Placebo-Controlled Trial
Role: lead
Long Duration Therapeutic Ultrasound for Tendon Healing
Role: lead
Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions
Role: lead
Long Duration Therapeutic Ultrasound on Tendon Injuries
Role: lead
Wearable Therapeutic Ultrasound Study for Knee Osteoarthritis
Role: lead
All 17 trials loaded